CNBM (03323) plans to issue corporate bonds not exceeding 2 billion yuan.
China Building Materials (03323) announced that the company plans to issue technology innovation corporate bonds (first tranche) for professional investors in 2026, with a maximum issuance size of 20 billion yuan (including 20 billion yuan). The first tranche of bonds is a 3-year fixed-rate bond, and the second tranche is a 5-year fixed-rate bond. The face interest rate of the first tranche of bonds is in the range of 1.40% to 2.40% (including the upper and lower limits), and the face interest rate of the second tranche of bonds is in the range of 1.50% to 2.50% (including the upper and lower limits). The funds raised from this tranche of bonds will be used to repay interest-bearing debts.
CNBM (03323) announces that the company plans to issue the 2026 Technology Innovation Corporate Bonds (Series 1) to professional investors. The issuance size will not exceed 2 billion yuan (including 2 billion yuan). The first series of bonds is a 3-year fixed-rate bond, and the second series is a 5-year fixed-rate bond. The face interest rate range for the first series of bonds is 1.40%-2.40% (including upper and lower limits), and the face interest rate range for the second series is 1.50-2.50% (including upper and lower limits). The funds raised from this bond issuance will be used to repay interest-bearing debts.
Related Articles
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
Change in controlling ownership: ETS GROUP (08031) receives a cash takeover offer at a discount of approximately 15.08%, and will resume trading on January 20th.
MODERN CHI MED (01643) plans to acquire a 30% stake in Shuzhi Health Global for 41.82 million Hong Kong dollars.
CMON is planning to offer a discount of approximately 16.67% in the maximum of 10.32 million shares, netting approximately 7.9 million Hong Kong dollars.
